1TILG H,PAGE D,TREHU E,et al. A method for detection of eryth- rocyte -bound interleukin -8 in humans during interleukin - 1 im- munotherapy[J]. J Immunol Met, 1993,163 (2) :253 -258.
2BAGGIOLINI M ,CLARK- LEWIS I. Interleukin- 8 ,a chemotactic and inflammatory cytokine [ J ]. FEBS Lett, 1992,307 ( 1 ) : 97 - 101.
3HARADA A,MUKAIDA N,MATSUSHIMA K, et al. lnterleukin 8 as a novel target for intervention therapy in acute inflammatory, disea- ses[J]. Mol Med Today, 1996, 2(11):482-489.
4LARSEN C G, ANDERSON A, APELLA E, et al. The neutrophil - activating protein ( NAP - 1 ) is also chemotactic for T lymphncytes [ J ]. Science, 1989,243 (4897) : 1464 - 1466.
5GILL E A, IMAIZUMI T, CORVETH H, et al. Bacterial LPS in- duces endothelin cells to synthesize a degranulating factor for nutro- phils[J]. FASEBJ, 1998,12 (9) :673.
6YEH F L ,LIN W L ,SHEN H D, et al. Changes in levels of serum IL-8 in burned patients[J]. Bums, 1997, 23 (7/8):555 -559.
7FREUND A,CHAUVEAU C,BROUILLET J P,et al. IL-8 expres- sion and its possible relationship with estrogen -receptor- negative status of breast cancer cells [ J ]. Oncogene, 2003,22 (2) : 256 - 265.
8BENDRE M S,GADDY -KURTEN D,MON - FOOTE T,et al. Ex- pression of interleukin- 8 and not parathyroid hormone- related protein by human breasl cancer cells correlates with bone metastasis in vivo [J]. Cancer Res,2002,62(19) :5571 -5579.
